Delivery Order SPE2DB24D1021-SPE2DB25FEYFQ
Award Date
7/3/25
Potential Completion Date
7/7/25
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dapagliflozin 10 mg tablets. The contract has a firm fixed price of $1,701.18 and a completion date of June 16, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,764.84, is for the delivery of DAPAGLIFLOZIN-METFOR ER 5-1000 60S pharmaceutical products. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 10, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of dapagliflozin-metformin extended-release 10-1000 mg tablets in 30-count packages. The contract has a firm fixed price and a ceiling value of $1,824.06, with a completion date of July 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,406.23 firm fixed-price contract is for the supply of 4,565,693,581 units of the pharmaceutical product dapagliflozin 10 mg tablets. The award has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp Corporate Office Division. The $4,295.42 firm-fixed-price delivery order is for the supply of 4565406421 dapagliflozin 10 mg tablets in 30-count packages. The contract has an ultimate completion date of August 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $19,472.75 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S. The contract has a completion date of June 16, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a $1,584.14 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication. The contract does not have a set-aside designation, indicating it was openly competed. The contract has an ultimate completion date of May 16, 2025. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,145.99 firm fixed price contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication. The contract has an ultimate completion date of June 13, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dapagliflozin 5 mg tablets. The contract has a firm fixed price of $1,969.76 and a performance period ending on May 20, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a $9,081.39 firm fixed-price delivery order for 4568628324 - DAPAGLIFLOZIN 5 MG TABLET 30S, a diabetes medication. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...